Chargement en cours...
Embryonic stem cells go from bench to bedside for Parkinson’s disease
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson’s disease. In preparation for clinical trial, Piao et al.(1) report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.
Enregistré dans:
| Publié dans: | Cell Rep Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8080240/ https://ncbi.nlm.nih.gov/pubmed/33948581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2021.100251 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|